Intellia Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $74M | 4.3M | 17.27 |
| 2025-03-31 | $17M | 2.4M | 7.11 |
| 2024-12-31 | $24M | 2.0M | 11.66 |
| 2024-09-30 | $21M | 1.0M | 20.55 |
| 2024-06-30 | $28M | 1.3M | 22.38 |
| 2024-03-31 | $29M | 1.1M | 27.51 |
| 2023-12-31 | $25M | 825k | 30.49 |
| 2023-09-30 | $25M | 796k | 31.62 |
| 2023-06-30 | $41M | 1.0M | 40.78 |
| 2023-03-31 | $32M | 860k | 37.27 |
| 2022-12-31 | $22M | 627k | 34.89 |
| 2022-06-30 | $44M | 848k | 51.76 |
| 2022-03-31 | $39M | 531k | 72.67 |
| 2021-12-31 | $121M | 1.0M | 118.24 |
| 2021-09-30 | $130M | 970k | 134.15 |
| 2021-03-31 | $63M | 786k | 80.25 |
| 2020-12-31 | $58M | 1.1M | 54.40 |
| 2020-09-30 | $11M | 540k | 19.88 |
| 2020-06-30 | $2.6M | 126k | 21.02 |
| 2019-12-31 | $1.4M | 94k | 14.67 |
| 2019-09-30 | $2.0M | 153k | 13.35 |
| 2019-06-30 | $3.6M | 221k | 16.37 |
| 2019-03-31 | $2.3M | 135k | 17.08 |
| 2018-12-31 | $2.2M | 162k | 13.66 |
| 2018-09-30 | $2.8M | 98k | 28.62 |
| 2018-06-30 | $2.4M | 87k | 27.36 |
| 2018-03-31 | $691k | 33k | 21.09 |
| 2017-12-31 | $2.5M | 130k | 19.22 |
| 2017-09-30 | $794k | 32k | 24.84 |
| 2017-06-30 | $777k | 49k | 16.00 |
| 2017-03-31 | $573k | 41k | 14.08 |
| 2016-12-31 | $2.1M | 163k | 13.10 |
| 2016-09-30 | $2.7M | 156k | 17.06 |
| 2016-06-30 | $3.1M | 144k | 21.35 |